BLT 0.00% 2.6¢ benitec biopharma limited

john rossi presenting at conferences

  1. 89 Posts.
    lightbulb Created with Sketch. 2
    John Rossi is presenting at a couple of upcoming conferences. In both cases he's talking about HIV therapies:

    1. ESF-EMBO "Antiviral Applications of RNA Interference" research conference, Spain, April

    "John Rossi City of Hope Beckman Research Institute, US RNAi and combinatorial gene therapy for HIV in hematopoietic stem cell and T-cell gene therapy settings"

    http://www.esf.org/fileadmin/be_user/activities/research_conferences/Docs_NEW/2008/2008-254pp.pdf

    2. Beyond Genome conference, San Francisco, June

    Strategies for RNAi-Based Therapies for the Treatment of HIV Infection John Rossi, Ph.D., Professor and Chair, Molecular Biology, Beckman Research Institute of the City of Hope

    http://www.beyondgenome.com/08rnx.asp
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.